⚲
|
Avoro Capital Advisors LLC
✚
|
|
---|---|
CRD # | 154091 |
SEC # | 801-74391 |
CIK # | 0001633313 |
AUM | $7.8 BB (2023-03-10) |
Employees | 16 (62% Investors, 0% Brokers) |
Phone | 212-937-4970 |
Address | 110 Greene Street New York, NY 10012 |
Source | [IAPD] [EDGAR] [Website] |
Total AUM ($BB) |
---|
Sector | Form 13F Holdings | Cap ($BB) | Value ($BB) |
---|---|---|---|
HZNP | 18.8 | 0.8 | |
APLS | 4.7 | 0.7 | |
UTHR | 10.6 | 0.6 | |
SRPT | 6.5 | 0.5 | |
ARGX | 19.8 | 0.5 | |
MDGL | 1.2 | 0.4 | |
BMRN | 15.4 | 0.4 | |
SGEN | 32.9 | 0.4 | |
ASND | 5.2 | 0.4 | |
FOLD | 3.0 | 0.3 | |
View All |
Holdings by Sector ($BB) |
---|
Type | Form D Funds | Date | Sold ($MM) | AUM ($MM) |
---|---|---|---|---|
VC | Avoro Ventures Fund LP | [2021-03-23] | 178.4 | 177.1 |
VC | venBio Global Strategic Fund II LP | [2016-03-29] | 337.0 | 315.2 |
HF | Avoro Life Sciences Fund LLC | [2012-02-22] | 1,447.4 | 7,600.3 |
VC | venBio Global Strategic Fund LP | [2012-02-22] | 177.0 | 178.8 |
AUM Breakdown | Accounts | AUM ($BB) |
---|---|---|
By Client Type | ||
(a) Individuals (other than high net worth individuals) | 0 | 0.0 |
(b) Individuals (high net worth individuals) | 0 | 0.0 |
(c) Banking or thrift institutions | 0 | 0.0 |
(d) Investment companies | 0 | 0.0 |
(e) Business development companies | 0 | 0.0 |
(f) Pooled investment vehicles | 3 | 7.8 |
(g) Pension and profit sharing plans | 0 | 0.0 |
(h) Charitable organizations | 0 | 0.0 |
(i) State or municipal government entities | 0 | 0.0 |
(j) Other investment advisers | 0 | 0.0 |
(k) Insurance companies | 0 | 0.0 |
(l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
(m) Corporations or other businesses not listed above | 0 | 0.0 |
(n) Other | 0 | 0.0 |
Total | 3 | 7.8 |
By Discretionary | ||
Discretionary | 3 | 7.8 |
Non-Discretionary | 0 | 0.0 |
Total | 3 | 7.8 |
By Non-United States Persons | ||
Non-United States Persons | 3.7 | |
United States Persons | 4.1 | |
Total | 3 | 7.8 |
Form D Directors | # Filings | # Firms | 2011 - 2024 | |
---|---|---|---|---|
Corey Goodman | 33 | |||
Robert Adelman | 23 | |||
Kurt von Emster | 17 | |||
Paul Brooke | 9 | |||
Behzad Aghazadeh | 5 | |||
Scott Epstein | 4 | |||
Avoro Capital GP LLC | 3 | |||
Avoro Capital LP | 3 | |||
venBio Select Advisor | 2 | |||
Avoro Capital Advisors LLC | 2 | |||
View All |
EDGAR Form | CIK | 2011 - 2024 |
---|---|---|
13F-HR | [0001633313] | |
3 | [0001633313] | |
4 | [0001633313] | |
SC 13D | [0001633313] | |
SC 13G | [0001633313] |
Form 3/4/5 Subject | 2011 - 2024 |
---|---|
CymaBay Therapeutics, Inc. | |
Avoro Capital Advisors LLC | |
Aghazadeh Behzad | |
Aadi Bioscience, Inc. | |
Avoro Ventures LLC | |
Immunomedics Inc | |
Mirati Therapeutics, Inc. |
Comparable Firms | State | AUM ($BB) |
---|---|---|
Irradiant Partners LP
✚
|
TX | 8.2 |
BlackRock Alternatives Management LLC
✚
|
NY | 8.2 |
Christofferson Robb & Company LLC
✚
|
NY | 8.1 |
Marble Point Credit Management LLC
✚
|
NY | 7.8 |
Eagle Point Credit Management LLC
✚
|
CT | 7.6 |
Matrix Capital Management Company LP
✚
|
MA | 7.6 |
Westbridge Capital US Advisors LP
✚
|
CA | 7.6 |
Sun Capital Advisors LP
✚
|
FL | 7.6 |
Pinnacle Asset Management LP
✚
|
NY | 7.4 |
Luxor Capital Group LP
✚
|
NY | 7.4 |